🔎 Trials Near Me

Nyumbani › Sarcoma ya Neuroendocrine

Majaribio ya kliniki ya Sarcoma ya Neuroendocrine yanayovutia washiriki nchini Marekani

Masomo 16 ya Sarcoma ya Neuroendocrine yanavutia washiriki katika vituo vya Marekani nzima.

Miji yenye masomo mengi

Kwa jimbo

Masomo yaliyosasishwa hivi karibuni

Maandishi rasmi ya utafiti (Kiingereza)

A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity

InaajiriHatua 2
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06406465

Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

InaajiriUtafiti wa uchunguzi
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT05237934

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07278479

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07080242

A Study of Armored CAR T Cells in People With Cancer

InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Sep 2026 · NCT07783477

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 31 Jul 2026 · NCT07129252

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Jul 2026 · NCT05652686

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

InaajiriHatua 1/2
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 13 Jul 2026 · NCT05000294

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Jul 2026 · NCT07174583

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

InaajiriHatua 1/2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 27 Mei 2026 · NCT03093116

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Des 2025 · NCT06943521

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.